Are patient-reported outcome instruments for ankylosing spondylitis fit for purpose for the axial spondyloarthritis patient? A qualitative and psychometric analysis (Q26823664)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Are patient-reported outcome instruments for ankylosing spondylitis fit for purpose for the axial spondyloarthritis patient? A qualitative and psychometric analysis	scientific article

Statements

scholarly article

1 reference

1 reference

Europe PubMed Central

Are patient-reported outcome instruments for ankylosing spondylitis fit for purpose for the axial spondyloarthritis patient? A qualitative and psychometric analysis (English)

1 reference

1 reference

based on heuristic

inferred from title

ankylosing spondylitis

1 reference

based on heuristic

inferred from title

Astrid van Tubergen

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26001635%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

author name string

Geoffroy Coteur

3

2 references

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26001635%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Peter M Black

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26001635%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

language of work or name

1 reference

publication date

October 2015

1 reference

2 references

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26001635%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

54

2 references

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26001635%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

10

2 references

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26001635%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

1842-1851

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26001635%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEV125

21 January 2018

The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEV125

21 January 2018

Diagnosis and classification in spondyloarthritis: identifying a chameleon

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEV125

21 January 2018

The early disease stage in axial spondylarthritis: results from the German Spondyloarthritis Inception Cohort

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEV125

21 January 2018

Therapy of ankylosing spondylitis--a review. Part I: Conventional medical treatment and surgical therapy

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEV125

21 January 2018

Prevalence of ankylosing spondylitis in males and females in a young middle-aged population of Tromsø, northern Norway

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEV125

21 January 2018

Prevalence of axial spondyloarthritis in United States rheumatology practices: Assessment of SpondyloArthritis International Society criteria versus rheumatology expert clinical diagnosis.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEV125

21 January 2018

Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEV125

21 January 2018

The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEV125

21 January 2018

Measures of symptoms and disease status in ankylosing spondylitis: Ankylosing Spondylitis Disease Activity Score (ASDAS), Ankylosing Spondylitis Quality of Life Scale (ASQoL), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylos

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEV125

21 January 2018

Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEV125

21 January 2018

Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEV125

21 January 2018

Certolizumab pegol plus methotrexate provides broad relief from the burden of rheumatoid arthritis: analysis of patient-reported outcomes from the RAPID 2 trial

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEV125

21 January 2018

New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS).

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEV125

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEV125

21 January 2018

Assessing the clinical significance of change scores recorded on subjective outcome measures

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEV125

21 January 2018

Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEV125

21 January 2018

How to measure disease activity in axial spondyloarthritis?

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEV125

21 January 2018

Responsiveness of the activities of daily living scale of the knee outcome survey and numeric pain rating scale in patients with patellofemoral pain

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEV125

21 January 2018

Development and psychometric evaluation of the Flexilevel Scale of Shoulder Function

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEV125

21 January 2018

Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEV125

21 January 2018

Impact of Certolizumab Pegol on Patient-Reported Outcomes in Patients With Axial Spondyloarthritis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEV125

21 January 2018

Clinical and imaging efficacy of infliximab in HLA-B27-Positive patients with magnetic resonance imaging-determined early sacroiliitis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEV125

21 January 2018

The risk of developing ankylosing spondylitis in HLA-B27 positive individuals. A comparison of relatives of spondylitis patients with the general population

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEV125

7 January 2021

based on heuristic

inferred from DOI database lookup

ASsessment in Ankylosing Spondylitis International Working Group/Spondylitis Association of America recommendations for conducting clinical trials in ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEV125

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined sacroiliitis: results of a twelve-week randomized, double-blind, placebo-controlled trial followed by an open-label extension up to week fifty-two

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEV125

7 January 2021

based on heuristic

inferred from DOI database lookup

ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEV125

7 January 2021

based on heuristic

inferred from DOI database lookup

Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEV125

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q26823664&oldid=2034595585"